Dan Cui

Dan Cui serves as the Vice President and Senior Director of DMPK and Clinical PK at Morphic Therapeutic since September 2017. Prior to this role, Dan held the position of Head of ADME at Teva Pharmaceuticals from January to August 2017, and was the Director of PPDM at Shire from January 2015 to December 2016. Dan's extensive career began at Merck in November 1996, where positions included Director of DMPK, Associate Director, and Scientist, focusing on areas such as ADME/PK and Mass Spectrometry.